Pharmaceutical expenditure in Italian hospitals is continuing to rise while overall reimbursable drug spending in the national health service dipped last year by 1%. The hospital sector's spending has been consistently well above budgeted levels and at the last estimate for 2008 registered an overshoot of 1.3 billion euros ($1.69 billion). Italy's drug agency, the Aifa, calculates savings on medicines in the period to November 2008 at 182.5 million euros , although in terms of spending within budget limits some regions of the country, mainly in the south and Lazio, registered above-budget levels.
In the case of the hospitals in the first 11 months of last year, drug spending reached 3.4 billion euros compared with a budget limit of 2.16 billion euros. This figure does not include vaccines or so-called class A items. December expenditure on medicines by the hospitals grew 3.8% against a legally-binding target level of 2.4%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze